Related Experiment Video
Updated: Jul 21, 2025

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells
Published on: July 12, 2022
The Emerging Role of Senotherapy in Cancer: A Comprehensive Review
Sarubala Malayaperumal1, Francesco Marotta2, Makalakshmi Murali Kumar1
1Faculty of Allied Health Sciences, Chettinad Academy of Research and Education (CARE), Kelambakkam, Chennai 603103, India.
Abstract:
Senotherapy, a promising therapeutic strategy, has drawn a lot attention recently due to its potential for combating cancer. Senotherapy refers to the targeting of senescent cells to restore tissue homeostasis and mitigate the deleterious effects associated with senescence. Senolytic drugs represent a promising avenue in cancer treatment, with the potential to target and modulate senescent cells to improve patient outcomes. The review highlights the intricate interplay between the senescence-associated secretory phenotype (SASP) and the tumor microenvironment, emphasizing the role of senescent cells in promoting chronic inflammation, immune evasion, and tumor-cell proliferation. It then explores the potential of senotherapy as a novel strategy for cancer therapy. This review addresses the emerging evidence on the combination of senotherapy with conventional cancer treatments, such as chemotherapy and immunotherapy.
Insights
Senotherapy targets senescent cells to combat cancer by modulating the tumor microenvironment. This approach, using senolytic drugs, shows promise in combination with traditional cancer treatments.
Area of Science:
- Oncology
- Cellular Biology
- Immunology
Background:
- Senotherapy targets senescent cells, which contribute to tissue dysfunction and disease.
- Senescent cells, through the senescence-associated secretory phenotype (SASP), influence the tumor microenvironment.
- SASP can promote inflammation, immune evasion, and tumor cell proliferation.
Purpose of the Study:
- To review the role of senescent cells and SASP in cancer.
- To explore senotherapy as a novel cancer treatment strategy.
- To discuss the combination of senotherapy with conventional cancer therapies.
Main Methods:
- Literature review of senotherapy and its role in cancer.
- Analysis of the interplay between senescent cells, SASP, and the tumor microenvironment.
- Examination of emerging evidence on combination therapies.
Main Results:
- Senescent cells and SASP play a complex role in cancer progression.
- Senotherapy demonstrates potential for cancer treatment by targeting senescent cells.
- Combination of senotherapy with chemotherapy and immunotherapy is an emerging area.
Conclusions:
- Senotherapy offers a novel therapeutic strategy for cancer.
- Targeting senescent cells can disrupt tumor-promoting mechanisms.
- Further research into senotherapy combinations is warranted for improved cancer outcomes.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy
Treatment Resistant Cancers
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

